• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 451/04 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropaneCyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring system

Patent holdings for IPC class C07D 451/04

Total number of patents in this class: 263

10-year publication summary

22
19
25
28
18
20
23
8
5
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Theravance Biopharma R&D IP, LLC
408
13
Remix Therapeutics Inc.
84
10
Skyhawk Therapeutics, Inc.
147
9
Novartis AG
10279
8
Purdue Pharma L.P.
493
8
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
872
8
Shionogi & Co., Ltd.
873
7
Janssen Pharmaceutica N.V.
3175
6
Curza Global, LLC
27
5
Rigel Pharmaceuticals, Inc.
507
5
University of Utah Research Foundation
1858
5
Bristol-myers Squibb Company
4725
4
Merck Patent GmbH
5725
4
BioMarin Pharmaceutical Inc.
400
4
Enanta Pharmaceuticals, Inc.
430
4
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
375
4
The University of Edinburgh
27
4
Shanghai Hansoh Biomedical Co., Ltd.
353
4
Nxera Pharma UK Limited
187
4
Glaxosmithkline Intellectual Property Development Limited
777
3
Other owners 144